Pascal and Francis Bibliographic Databases

Help

Search results

Your search

ct.\*:("Cardiovascular system")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 160751

  • Page / 6431

Export

Selection :

  • and

Design, Synthesis and Pharmacological Screening of Novel Antihypertensive Agents Using Hybrid ApproachBHANDARI, Shashikant V; BOTHARA, Kailash G; PATIL, Ajit A et al.Bioorganic & medicinal chemistry. 2009, Vol 17, Num 1, pp 390-400, issn 0968-0896, 11 p.Article

Memory T Cells Mediate Cardiac Allograft Vasculopathy and are Inactivated by Anti-OX40L Monoclonal AntibodyHAO WANG; ZHIXIANG ZHANG; WEIJUN TIAN et al.Cardiovascular drugs and therapy. 2014, Vol 28, Num 2, pp 115-122, issn 0920-3206, 8 p.Article

Atorvastatin Active Metabolite Inhibits Oxidative Modification of Small Dense Low-Density LipoproteinJACOB, Robert F; WALTER, Mary F; SELF-MEDLIN, Yehudi et al.Journal of cardiovascular pharmacology. 2013, Vol 62, Num 2, pp 160-166, issn 0160-2446, 7 p.Article

HMG-CoA Reductase Inhibitors, Simvastatin and Atorvastatin, Downregulate ABCG1-mediated Cholesterol Efflux in Human MacrophagesWEI WANG; WEI SONG; YU WANG et al.Journal of cardiovascular pharmacology. 2013, Vol 62, Num 1, pp 90-97, issn 0160-2446, 8 p.Article

Myocardial Rac1 Exhibits Partial Involvement in Thyroxin-induced Cardiomyocyte Hypertrophy and Its Inhibition Is Not Sufficient to Improve Cardiac Dysfunction or Contractile Abnormalities in Mouse Papillary MusclesELNAKISH, Mohammad T; MOLDOVAN, Leni; KHAN, Mahmood et al.Journal of cardiovascular pharmacology. 2013, Vol 61, Num 6, pp 536-544, issn 0160-2446, 9 p.Article

Electrocardiographic Safety of Cangrelor, a New Intravenous Antiplatelet Agent: A Randomized, Double-blind, Placebo- and Moxifloxacin-controlled Thorough QT StudyGREEN, Cynthia L; WHELLAN, David J; LAMBE, Lindsay et al.Journal of cardiovascular pharmacology. 2013, Vol 62, Num 5, pp 466-478, issn 0160-2446, 13 p.Article

Salidroside Improves Doxorubicin-induced Cardiac Dysfunction by Suppression of Excessive Oxidative Stress and Cardiomyocyte ApoptosisWANG, Xu-Lei; XUE WANG; WEI JIANG et al.Journal of cardiovascular pharmacology. 2013, Vol 62, Num 6, pp 512-523, issn 0160-2446, 12 p.Article

Opportunity Nox: The Future of NADPH Oxidases as Therapeutic Targets in Cardiovascular DiseaseSTREETER, Jennifer; THIEL, William; BRIEGER, Katharine et al.Cardiovascular therapeutics (Print). 2013, Vol 31, Num 3, pp 125-137, issn 1755-5914, 13 p.Article

Resveratrol Protects HUVECs from Oxidized-LDL Induced Oxidative Damage by Autophagy Upregulation via the AMPK/SIRT1 PathwayHUALEI GUO; YANLING CHEN; LIZHEN LIAO et al.Cardiovascular drugs and therapy. 2013, Vol 27, Num 3, pp 189-198, issn 0920-3206, 10 p.Article

Aspirin Dose Increase from 75 to 150 mg Suppresses Red Blood Cell Contribution to Suboptimal Platelet Response to Aspirin in Patients with CADKAROLCZAK, Kamil; PIETRUSZYNSKI, Robert; DRZEWOSKI, Jozef et al.Cardiovascular drugs and therapy. 2013, Vol 27, Num 6, pp 549-558, issn 0920-3206, 10 p.Article

Enhanced NO Signaling in Patients with Takotsubo Cardiomyopathy: Short-Term Pain, Long-Term Gain?NGUYEN, Thanh H; NEIL, Christopher J; SVERDLOV, Aaron L et al.Cardiovascular drugs and therapy. 2013, Vol 27, Num 6, pp 541-547, issn 0920-3206, 7 p.Article

Ezetimibe Inhibits Lymphatic Transport of Esterified Cholesterol but Not Free Cholesterol in Thoracic Lymph Duct-Cannulated RatsSHIROUCHI, Bungo; NAKAMURA, Yuri; FURUKAWA, Yumiko et al.Cardiovascular drugs and therapy. 2012, Vol 26, Num 5, pp 427-431, issn 0920-3206, 5 p.Article

Fenoldopam in Critically III Patients with Early Renal Dysfunction. A Crossover StudyCOBAS, Miguel; PAPARCURI, Gian; DE LA PENA, Maria et al.Cardiovascular therapeutics (Print). 2011, Vol 29, Num 4, pp 280-284, issn 1755-5914, 5 p.Article

Mesenchymal Stem Cells for Cardiovascular RegenerationKURAITIS, Drew; RUEL, Marc; SUURONEN, Erik J et al.Cardiovascular drugs and therapy. 2011, Vol 25, Num 4, pp 349-362, issn 0920-3206, 14 p.Article

Protection of Endothelial Cells, Inhibition of Neointimal Hyperplasia by β-elemene in an Injured ArteryLINGYAN WU; GUIXUE WANG; SHUTANG TANG et al.Cardiovascular drugs and therapy. 2011, Vol 25, Num 3, pp 233-242, issn 0920-3206, 10 p.Article

The Effect of SEX/Gender on Cardiovascular Pharmacology : Gender Differences in Cardiovascular Diseases. A Need for ActionFRANCONI, Flavia; CARRU, Ciriaco; MALORNI, Walter et al.Current pharmaceutical design (Print). 2011, Vol 17, Num 11, pp 1095-1107, issn 1381-6128, 13 p.Article

En bref - Nésiritide : retour vers le futur = In brief: nesiritide (Natrecor)The Medical letter on drugs and therapeutics (Edition française). 2011, Vol 33, Num 25, issn 0253-8512, p. 100Article

Ascorbic Acid Infusion Blunts CD40L Upregulation in Patients Undergoing Coronary StentPIGNATELLI, Pasquale; TANZILLI, Gaetano; VIOLI, Francesco et al.Cardiovascular therapeutics (Print). 2011, Vol 29, Num 6, pp 385-394, issn 1755-5914, 10 p.Article

An arginine-vasopressin V2 receptor antagonist, Tolvaptan for treatment of heart failure with volume overload - Evidence from nonclinical studies to clinical trialsHORI, Masatsugu.Cardiovascular drugs and therapy. 2011, Vol 25, issn 0920-3206, 100 p., SUP1Serial Issue

Anti-edematous Effects of Tolvaptan in Experimental Rodent ModelsMIYAZAKI, Toshiki; SAKAMOTO, Yuki; YAMASHITA, Tatsuya et al.Cardiovascular drugs and therapy. 2011, Vol 25, issn 0920-3206, S77-S82, SUP1Article

Functional Assessment of HDL: Moving Beyond Static Measures for Risk AssessmentROSENSON, Robert S.Cardiovascular drugs and therapy. 2010, Vol 24, Num 1, pp 71-75, issn 0920-3206, 5 p.Article

A Multicenter, Eight-Week Treatment, Single-Step Titration, Open-Label Study Assessing the Percentage of Korean Dyslipidemic Patients Achieving LDL Cholesterol Target with Atorvastatin Starting Doses of 10 mg, 20 mg and 40 mgCHEOL WHAN LEE; BAEK, Sang-Hong; AHN, Young-Keun et al.Cardiovascular drugs and therapy. 2010, Vol 24, Num 2, pp 181-188, issn 0920-3206, 8 p.Article

Neonatal Exendin-4 Leads to Protection from Reperfusion Injury and Reduced Rates of Oxidative Phosphorylation in the Adult Rat HeartBROWN, Suzanne B; LIBONATI, Joseph R; SELAK, Mary A et al.Cardiovascular drugs and therapy. 2010, Vol 24, Num 3, pp 197-205, issn 0920-3206, 9 p.Article

Role of Dual Antiplatelet Therapy in Symptomatic Patients with Established Vascular Disease: Putting the CHARISMA Trial into Therapeutic PerspectiveBODEN, William E; FLATHER, Marcus D; BHATT, Deepak L et al.Cardiovascular drugs and therapy. 2010, Vol 24, Num 3, pp 207-216, issn 0920-3206, 10 p.Article

Cytochrome P450 Pathway Contributes to Methanandamide-induced Vasorelaxation in Rat AortaLOPEZ-MIRANDA, Visitación; DANNERT, M. Teresa; HERRADON, Esperanza et al.Cardiovascular drugs and therapy. 2010, Vol 24, Num 5-6, pp 379-389, issn 0920-3206, 11 p.Article

  • Page / 6431